The Role of MicroRNA in the Myocarditis: a Small Actor for a Great Role.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
07 2023
Historique:
accepted: 24 04 2023
medline: 30 6 2023
pubmed: 3 6 2023
entrez: 3 6 2023
Statut: ppublish

Résumé

Myocarditis is an inflammation of the myocardium secondary to a variety of agents such as infectious pathogens, toxins, drugs, and autoimmune disorders. In our review, we provide an overview of miRNA biogenesis and their role in the etiology and pathogenesis of myocarditis, evaluating future directions for myocarditis management. Advances in genetic manipulation techniques allowed to demonstrate the important role of RNA fragments, especially microRNAs (miRNAs), in cardiovascular pathogenesis. miRNAs are small non-coding RNA molecules that regulate the post-transcriptional gene expression. Advances in molecular techniques allowed to identify miRNA's role in pathogenesis of myocarditis. miRNAs are related to viral infection, inflammation, fibrosis, and apoptosis of cardiomyocytes, making them not only promising diagnostic markers but also prognostics and therapeutic targets in myocarditis. Of course, further real-world studies will be needed to assess the diagnostic accuracy and applicability of miRNA in the myocarditis diagnosis.

Identifiants

pubmed: 37269474
doi: 10.1007/s11886-023-01888-5
pii: 10.1007/s11886-023-01888-5
pmc: PMC10307691
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-648

Informations de copyright

© 2023. The Author(s).

Références

Trends Biochem Sci. 2016 Oct;41(10):883-892
pubmed: 27597517
Mol Oncol. 2017 Dec;11(12):1673-1686
pubmed: 29024380
Allergy. 2015 Sep;70(9):1121-9
pubmed: 25944053
J Exp Med. 2005 Jul 18;202(2):261-9
pubmed: 16009718
Arch Virol. 2013 Sep;158(9):1953-63
pubmed: 23588407
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):20-27
pubmed: 29193905
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Circ Res. 2016 Feb 5;118(3):496-514
pubmed: 26846643
Nat Struct Mol Biol. 2006 Dec;13(12):1097-101
pubmed: 17099701
Dev Cell. 2009 Nov;17(5):662-73
pubmed: 19922871
Curr Top Med Chem. 2019;19(21):1918-1947
pubmed: 31393249
Cancer Lett. 2018 Jul 28;427:63-73
pubmed: 29679611
Drug Discov Today. 2019 Jan;24(1):233-240
pubmed: 29852125
Bioessays. 2016 Apr;38(4):367-78
pubmed: 26934338
Circulation. 2004 Dec 7;110(23):3534-9
pubmed: 15557377
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jun 24;46(6):450-457
pubmed: 29925181
J Mol Med (Berl). 2016 Sep;94(9):1063-79
pubmed: 27052830
Cardiovasc Pathol. 2016 Mar-Apr;25(2):120-6
pubmed: 26764146
Science. 2007 Apr 27;316(5824):604-8
pubmed: 17463289
J Cell Biochem. 2019 Apr;120(4):6605-6613
pubmed: 30484891
Mol Immunol. 2020 Jan;117:73-83
pubmed: 31743855
Nature. 2007 Jul 5;448(7149):83-6
pubmed: 17589500
Curr Pharm Des. 2014;20(14):2347-70
pubmed: 23844813
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
Int J Cardiol. 2014 Aug 20;175(3):409-17
pubmed: 24910366
J Cardiovasc Transl Res. 2018 Aug;11(4):319-328
pubmed: 29916103
Vascul Pharmacol. 2019 Mar;114:31-48
pubmed: 30389614
J Immunol. 2011 Sep 15;187(6):3362-73
pubmed: 21849676
Cardiovasc Res. 2009 Aug 1;83(3):465-72
pubmed: 19398468
Nucleic Acids Res. 2013 Apr 1;41(6):3760-71
pubmed: 23389951
Circ Res. 2009 Sep 11;105(6):585-94
pubmed: 19679836
Nature. 2011 Jan 20;469(7330):336-42
pubmed: 21248840
J Exp Med. 2005 May 2;201(9):1367-73
pubmed: 15867090
J Clin Invest. 2015 Mar 2;125(3):1069-80
pubmed: 25642768
Circ Res. 2012 Aug 3;111(4):415-25
pubmed: 22715471
Eur J Heart Fail. 2016 Dec;18(12):1442-1451
pubmed: 27292200
J Allergy Clin Immunol. 2014 May;133(5):1429-38, 1438.e1-7
pubmed: 24373357
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178
pubmed: 19096030
N Engl J Med. 2022 Oct 20;387(16):1488-1500
pubmed: 36260793
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Acta Pharmacol Sin. 2018 Jul;39(7):1073-1084
pubmed: 29877320
PLoS Negl Trop Dis. 2015 Jun 18;9(6):e0003828
pubmed: 26086673
Nat Rev Cardiol. 2015 Nov;12(11):670-80
pubmed: 26194549
Mol Cell Biochem. 2017 May;429(1-2):199-210
pubmed: 28247213
Mol Immunol. 2013 Jul;54(3-4):435-42
pubmed: 23416424
Hum Pathol. 2015 Nov;46(11):1760-8
pubmed: 26362204
Circ Cardiovasc Genet. 2010 Dec;3(6):499-506
pubmed: 20921333
Cell Mol Life Sci. 2013 Dec;70(23):4631-44
pubmed: 23811937
J Am Coll Cardiol. 2016 Nov 29;68(21):2348-2364
pubmed: 27884253
Int J Cardiol. 2017 Feb 15;229:75-81
pubmed: 27913008
J Cell Physiol. 2012 Feb;227(2):850-6
pubmed: 21769867
Immunity. 2010 Oct 29;33(4):607-19
pubmed: 20888269
Mol Cell Biochem. 2012 Mar;362(1-2):141-8
pubmed: 22045061
Virology. 2019 Mar;529:169-176
pubmed: 30711774
N Engl J Med. 2021 May 27;384(21):2014-2027
pubmed: 34042389
Eur Heart J. 2015 Nov 7;36(42):2909-19
pubmed: 26206211
Eur J Heart Fail. 2012 Feb;14(2):202-10
pubmed: 22186680
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Front Immunol. 2018 May 07;9:992
pubmed: 29867969
Lancet. 2012 Feb 25;379(9817):738-47
pubmed: 22185868

Auteurs

Cristina Chimenti (C)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy. cristina.chimenti@uniroma1.it.

Michele Magnocavallo (M)

Cardiology Division, Arrhythmology Unit, S. Giovanni Calibita Hospital, Isola Tiberina, Rome, Italy.

Giampaolo Vetta (G)

Department of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Mesina, Italy.

Maria Alfarano (M)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Giulia Manguso (G)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Francesco Ajmone (F)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Federico Ballatore (F)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Jacopo Costantino (J)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Piera Ciaramella (P)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Paolo Severino (P)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Fabio Miraldi (F)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Carlo Lavalle (C)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Carmine Dario Vizza (CD)

Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH